KR910000417B1 - 1,7-디하이드로-피롤로[3,4-e][1,4]디아제핀-2(3H)-온 유도체의 제조방법 - Google Patents
1,7-디하이드로-피롤로[3,4-e][1,4]디아제핀-2(3H)-온 유도체의 제조방법 Download PDFInfo
- Publication number
- KR910000417B1 KR910000417B1 KR1019830004230A KR830004230A KR910000417B1 KR 910000417 B1 KR910000417 B1 KR 910000417B1 KR 1019830004230 A KR1019830004230 A KR 1019830004230A KR 830004230 A KR830004230 A KR 830004230A KR 910000417 B1 KR910000417 B1 KR 910000417B1
- Authority
- KR
- South Korea
- Prior art keywords
- methyl
- hydrogen
- compound
- formula
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 0 C*C(*)(CCCC1)C[C@@]1C=NC(C(N(*)c(c(C)c(C)[n]1*)c1I)=O)O Chemical compound C*C(*)(CCCC1)C[C@@]1C=NC(C(N(*)c(c(C)c(C)[n]1*)c1I)=O)O 0.000 description 4
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8225582 | 1982-09-08 | ||
| GB8225582 | 1982-09-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR840006248A KR840006248A (ko) | 1984-11-22 |
| KR910000417B1 true KR910000417B1 (ko) | 1991-01-25 |
Family
ID=10532762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019830004230A Expired KR910000417B1 (ko) | 1982-09-08 | 1983-09-08 | 1,7-디하이드로-피롤로[3,4-e][1,4]디아제핀-2(3H)-온 유도체의 제조방법 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4508730A (cg-RX-API-DMAC7.html) |
| EP (1) | EP0102602B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPS5965093A (cg-RX-API-DMAC7.html) |
| KR (1) | KR910000417B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE51230T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU566404B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA1199633A (cg-RX-API-DMAC7.html) |
| DE (1) | DE3381355D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK161077C (cg-RX-API-DMAC7.html) |
| ES (2) | ES525442A0 (cg-RX-API-DMAC7.html) |
| GR (1) | GR79626B (cg-RX-API-DMAC7.html) |
| IE (1) | IE56043B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL69473A (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA835899B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60208488A (ja) * | 1984-04-03 | 1985-10-21 | Nippon Mining Co Ltd | スラグからの有価金属の回収法 |
| HK1212972A1 (zh) | 2013-02-22 | 2016-06-24 | Bayer Pharma Aktiengesellschaft | 作爲bet-蛋白抑制剂用於治疗过度增殖性疾病的吡咯并-和吡唑并-三唑并二氮杂卓 |
| CA2901805A1 (en) | 2013-02-22 | 2014-08-28 | Bayer Pharma Aktiengesellschaft | 4-substituted pyrrolo- and pyrazolo-diazepines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3553207A (en) * | 1968-12-16 | 1971-01-05 | Parke Davis & Co | Phenylpyrazolodiazepinone compounds |
| US3553210A (en) * | 1968-12-16 | 1971-01-05 | Parke Davis & Co | 3-methyl-8-phenylpyrazolo(4,3-e)(1,4)diazepin-5(1h)-one, 7-oxide compounds |
| GB1433103A (en) * | 1974-03-20 | 1976-04-22 | Lepetit Spa | Pharmacologically active pyrrolodiazepines |
| GR76455B (cg-RX-API-DMAC7.html) * | 1981-06-04 | 1984-08-10 | Lepetit Spa | |
| IT1167788B (it) * | 1981-06-08 | 1987-05-13 | Lepetit Spa | Derivati pirrolo-diazepinici |
-
1983
- 1983-08-09 US US06/521,774 patent/US4508730A/en not_active Expired - Fee Related
- 1983-08-11 ZA ZA835899A patent/ZA835899B/xx unknown
- 1983-08-11 AU AU17900/83A patent/AU566404B2/en not_active Ceased
- 1983-08-12 IL IL69473A patent/IL69473A/xx unknown
- 1983-08-27 AT AT83108446T patent/ATE51230T1/de not_active IP Right Cessation
- 1983-08-27 DE DE8383108446T patent/DE3381355D1/de not_active Expired - Lifetime
- 1983-08-27 EP EP83108446A patent/EP0102602B1/en not_active Expired - Lifetime
- 1983-08-29 GR GR72324A patent/GR79626B/el unknown
- 1983-08-30 DK DK394483A patent/DK161077C/da active
- 1983-09-07 ES ES525442A patent/ES525442A0/es active Granted
- 1983-09-07 IE IE2098/83A patent/IE56043B1/en not_active IP Right Cessation
- 1983-09-07 JP JP58163392A patent/JPS5965093A/ja active Granted
- 1983-09-07 CA CA000436167A patent/CA1199633A/en not_active Expired
- 1983-09-08 KR KR1019830004230A patent/KR910000417B1/ko not_active Expired
-
1984
- 1984-05-14 ES ES532487A patent/ES532487A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IE56043B1 (en) | 1991-03-27 |
| DK394483A (da) | 1984-03-09 |
| CA1199633A (en) | 1986-01-21 |
| EP0102602B1 (en) | 1990-03-21 |
| DK161077B (da) | 1991-05-27 |
| JPH0447672B2 (cg-RX-API-DMAC7.html) | 1992-08-04 |
| AU566404B2 (en) | 1987-10-22 |
| IL69473A (en) | 1985-12-31 |
| US4508730A (en) | 1985-04-02 |
| ZA835899B (en) | 1984-07-25 |
| DK394483D0 (da) | 1983-08-30 |
| DK161077C (da) | 1991-11-18 |
| ES8503000A1 (es) | 1985-02-01 |
| JPS5965093A (ja) | 1984-04-13 |
| EP0102602A1 (en) | 1984-03-14 |
| ES525442A0 (es) | 1985-02-01 |
| IL69473A0 (en) | 1983-11-30 |
| IE832098L (en) | 1984-03-08 |
| KR840006248A (ko) | 1984-11-22 |
| ES8507551A1 (es) | 1985-09-01 |
| AU1790083A (en) | 1984-03-15 |
| DE3381355D1 (de) | 1990-04-26 |
| ATE51230T1 (de) | 1990-04-15 |
| GR79626B (cg-RX-API-DMAC7.html) | 1984-10-31 |
| ES532487A0 (es) | 1985-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4098786A (en) | Benzodiazepin derivatives | |
| DE2609486C2 (cg-RX-API-DMAC7.html) | ||
| JPH0433791B2 (cg-RX-API-DMAC7.html) | ||
| KR100255131B1 (ko) | 피롤로아제핀유도체를함유하는의약 | |
| CA1229088A (en) | 5-(4-vinyl or 4-ethynylbenzoyl)-1,2-dihydro-3h- pyrrolo-¬1,2-a|-pyrrole-1-carboxylic acids and derivatives thereof | |
| JPH0351704B2 (cg-RX-API-DMAC7.html) | ||
| US4112112A (en) | Pyrrolo[2,1-b] [3]benzazepines useful for producing a skeletal muscle relaxing or tranquilizing effect | |
| US4261997A (en) | 4-Alkyl-pyrazolo[5,1-b]-quinazolin-9(4H)-ones and anti-allergic compositions containing them | |
| EP0102602B1 (en) | 1,7-dihydro-pyrrolo(3,4-e)(1,4)diazepin-2(3h)-one derivatives, a process for preparing them and their use as anticonvulsant and antianxiety agents | |
| US4022766A (en) | Pharmacologically active pyrrolodiazepines | |
| US4042600A (en) | Pyrolysis of 2-sulfochloride benzoates | |
| US4701466A (en) | Dibenz[be]oxepin-acetic acid derivatives, the preparation thereof and their application in therapy | |
| DE69230730T2 (de) | VERFAHREN ZUR HERSTELLUNG VON BENZO[b]NAPHTHYRIDINEN | |
| JPS6137249B2 (cg-RX-API-DMAC7.html) | ||
| EP0066762B1 (en) | 1,7-dihydro-pyrrolo(3,4-e)(1,4)diazepin-2(1h)-one derivatives | |
| US3329701A (en) | Cyanobenzophenones | |
| US3927015A (en) | 2-(3-Hydroxyaminomethyl-S-triazol-4-yl)benzophenones | |
| FR2593179A1 (fr) | Derives d'imidazo(1,2-a)quinoleines, leur preparation et leur application en therapeutique | |
| US3499027A (en) | Intermediates for preparing certain 1,4-benzodiazepin-2-(1h)-ones | |
| US4244869A (en) | Benzodiazepine derivatives and process of making them | |
| IE58497B1 (en) | New process for the preparation of derivatives of 4h-1, 2,4-triazole, the new triazoles so obtained, their use as medicaments and the pharmaceutical compositions containing them | |
| EP0045519B1 (de) | Pyrrolo(3,4-d)(2)benzazepine, Zwischenprodukte und Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel | |
| SU683618A3 (ru) | Способ получени производных бензодиазепина | |
| CA1200244A (en) | 5-aroyl-6,-alkylthio-1,2-dihydro-3h-pyrrolo[1,2- 1] pyrrole-1-carboxylic acids and derivatives thereof | |
| KR880001659B1 (ko) | 1,7-디하이드로-피롤로[3,4-e][1,4]디아제핀-2-(1H)-온 유도체 및 이의 중간체의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
St.27 status event code: A-0-1-A10-A12-nap-PA0109 |
|
| R17-X000 | Change to representative recorded |
St.27 status event code: A-3-3-R10-R17-oth-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| G160 | Decision to publish patent application | ||
| PG1605 | Publication of application before grant of patent |
St.27 status event code: A-2-2-Q10-Q13-nap-PG1605 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U11-oth-PR1002 Fee payment year number: 1 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 19940126 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 19940126 |
|
| R18-X000 | Changes to party contact information recorded |
St.27 status event code: A-5-5-R10-R18-oth-X000 |